Arbutus Biopharma Corp (ABUS) › Total AssetsArbutus Biopharma Corp (ABUS) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $71.72M2014: $118.18M2015: $712.29M2016: $275.92M2017: $237.16M2018: $227.91M2019: $105.53M2020: $137.08M2021: $204.49M2022: $195.42M2023: $144.40M2024: $131.71M2025: $94.62M$94.62M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$94.62M-28.2%2024$131.71M-8.8%2023$144.40M-26.1%2022$195.42M-4.4%2021$204.49M+49.2%2020$137.08M+29.9%2019$105.53M-53.7%2018$227.91M-3.9%2017$237.16M-14.0%2016$275.92M-61.3%2015$712.29M+502.7%2014$118.18M+64.8%2013$71.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share